메뉴 건너뛰기




Volumn 117, Issue 25, 2011, Pages 6856-6865

Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HAPRIL.01A; MONOCLONAL ANTIBODY HAPRIL.03A; UNCLASSIFIED DRUG;

EID: 79959531760     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-330852     Document Type: Article
Times cited : (49)

References (49)
  • 1
    • 58149152733 scopus 로고    scopus 로고
    • "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival
    • Kimberley FC, Hahne M, Medema JP. "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival. J Cell Physiol. 2009;218(1):1-8.
    • (2009) J Cell Physiol , vol.218 , Issue.1 , pp. 1-8
    • Kimberley, F.C.1    Hahne, M.2    Medema, J.P.3
  • 3
    • 0034729769 scopus 로고    scopus 로고
    • Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
    • DOI 10.1016/S0960-9822(00)00566-2
    • Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol. 2000;10(13):785-788. (Pubitemid 30466942)
    • (2000) Current Biology , vol.10 , Issue.13 , pp. 785-788
    • Marsters, S.A.1    Yan, M.2    Pitti, R.M.3    Haas, P.E.4    Dixit, V.M.5    Ashkenazi, A.6
  • 4
    • 0034606225 scopus 로고    scopus 로고
    • A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth
    • Rennert P, Schneider P, Cachero TG, et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med. 2000;192(11):1677-1684.
    • (2000) J Exp Med , vol.192 , Issue.11 , pp. 1677-1684
    • Rennert, P.1    Schneider, P.2    Cachero, T.G.3
  • 5
    • 0034634625 scopus 로고    scopus 로고
    • Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS
    • Wu Y, Bressette D, Carrell JA, et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem. 2000;275(45):35478-35485.
    • (2000) J Biol Chem , vol.275 , Issue.45 , pp. 35478-35485
    • Wu, Y.1    Bressette, D.2    Carrell, J.A.3
  • 6
    • 5944227779 scopus 로고    scopus 로고
    • APRIL and TALL-I and receptors BCMA and TACI: System for regulating humoral immunity
    • Yu G, Boone T, Delaney J, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol. 2000;1(3):252-256.
    • (2000) Nat Immunol , vol.1 , Issue.3 , pp. 252-256
    • Yu, G.1    Boone, T.2    Delaney, J.3
  • 10
    • 48749100460 scopus 로고    scopus 로고
    • APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa
    • Huard B, McKee T, Bosshard C, et al. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest. 2008;118(8):2887-2895.
    • (2008) J Clin Invest , vol.118 , Issue.8 , pp. 2887-2895
    • Huard, B.1    McKee, T.2    Bosshard, C.3
  • 11
    • 70349314412 scopus 로고    scopus 로고
    • The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking
    • Kimberley FC, van Bostelen L, Cameron K, et al. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J. 2009;23(5):1584-1595.
    • (2009) FASEB J , vol.23 , Issue.5 , pp. 1584-1595
    • Kimberley, F.C.1    Van Bostelen, L.2    Cameron, K.3
  • 12
    • 33947592601 scopus 로고    scopus 로고
    • TACI regulates IgA production by APRIL in collaboration with HSPG
    • DOI 10.1182/blood-2006-08-041772
    • Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood. 2007;109(7):2961- 2967. (Pubitemid 46482094)
    • (2007) Blood , vol.109 , Issue.7 , pp. 2961-2967
    • Sakurai, D.1    Hase, H.2    Kanno, Y.3    Kojima, H.4    Okumura, K.5    Kobata, T.6
  • 14
    • 33644755600 scopus 로고    scopus 로고
    • An APRIL to remember: Novel TNF ligands as therapeutic targets
    • DOI 10.1038/nrd1982, PII N1982
    • Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006;5(3):235-246. (Pubitemid 43336036)
    • (2006) Nature Reviews Drug Discovery , vol.5 , Issue.3 , pp. 235-246
    • Dillon, S.R.1    Gross, J.A.2    Ansell, S.M.3    Novak, A.J.4
  • 18
    • 41949138741 scopus 로고    scopus 로고
    • APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
    • Belnoue E, Pihlgren M, McGaha TL, et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood. 2008;111(5):2755-2764.
    • (2008) Blood , vol.111 , Issue.5 , pp. 2755-2764
    • Belnoue, E.1    Pihlgren, M.2    McGaha, T.L.3
  • 21
    • 49649112162 scopus 로고    scopus 로고
    • Thymus-independent class switch recombination is affected by APRIL
    • Hardenberg G, van Bostelen L, Hahne M, Medema JP. Thymus-independent class switch recombination is affected by APRIL. Immunol Cell Biol. 2008;86(6):530-534.
    • (2008) Immunol Cell Biol , vol.86 , Issue.6 , pp. 530-534
    • Hardenberg, G.1    Van Bostelen, L.2    Hahne, M.3    Medema, J.P.4
  • 22
    • 33846258010 scopus 로고    scopus 로고
    • BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway
    • DOI 10.1182/blood-2006-06-027755
    • Endo T, Nishio M, Enzler T, et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood. 2007;109(2):703-710. (Pubitemid 46105972)
    • (2007) Blood , vol.109 , Issue.2 , pp. 703-710
    • Endo, T.1    Nishio, M.2    Enzler, T.3    Cottam, H.B.4    Fukuda, T.5    James, D.F.6    Karin, M.7    Kipps, T.J.8
  • 23
    • 67149099805 scopus 로고    scopus 로고
    • A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation
    • Gupta M, Dillon SR, Ziesmer SC, et al. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood. 2009;113(21):5206-5216.
    • (2009) Blood , vol.113 , Issue.21 , pp. 5206-5216
    • Gupta, M.1    Dillon, S.R.2    Ziesmer, S.C.3
  • 28
    • 55049131371 scopus 로고    scopus 로고
    • Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia
    • Molica S, Digiesi G, Mauro F, et al. Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia. Leuk Res. 2009;33(1):162-165.
    • (2009) Leuk Res , vol.33 , Issue.1 , pp. 162-165
    • Molica, S.1    Digiesi, G.2    Mauro, F.3
  • 29
    • 36348943503 scopus 로고    scopus 로고
    • APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: Prognostic relevance of APRIL for survival
    • DOI 10.3324/haematol.10317
    • Planelles L, Castillo-Gutierrez S, Medema JP, Morales-Luque A, Merle-Beral H, Hahne M. APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica. 2007;92(9):1284-1285. (Pubitemid 350144199)
    • (2007) Haematologica , vol.92 , Issue.9 , pp. 1284-1285
    • Planelles, L.1    Castillo-Gutierrez, S.2    Medema, J.P.3    Morales-Luque, A.4    Merle-Beral, H.5    Hahne, M.6
  • 30
    • 67650721105 scopus 로고    scopus 로고
    • APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop
    • Moreaux J, Sprynski AC, Dillon SR, et al. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop. Eur J Haematol. 2009;83(2):119-129.
    • (2009) Eur J Haematol , vol.83 , Issue.2 , pp. 119-129
    • Moreaux, J.1    Sprynski, A.C.2    Dillon, S.R.3
  • 31
    • 54949118810 scopus 로고    scopus 로고
    • Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells
    • Gatto B. Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells. Curr Opin Investig Drugs. 2008;9(11):1216-1227.
    • (2008) Curr Opin Investig Drugs , vol.9 , Issue.11 , pp. 1216-1227
    • Gatto, B.1
  • 32
    • 78649955057 scopus 로고    scopus 로고
    • Belimumab: A BLyS-specific inhibitor for systemic lupus erythematosus
    • Wiglesworth AK, Ennis KM, Kockler DR. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus. Ann Pharmacother. 2010;44(12):1955-1961.
    • (2010) Ann Pharmacother , vol.44 , Issue.12 , pp. 1955-1961
    • Wiglesworth, A.K.1    Ennis, K.M.2    Kockler, D.R.3
  • 35
    • 13544261427 scopus 로고    scopus 로고
    • Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA
    • DOI 10.1021/bi048227k
    • Day ES, Cachero TG, Qian F, et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry. 2005;44(6):1919-1931. (Pubitemid 40223621)
    • (2005) Biochemistry , vol.44 , Issue.6 , pp. 1919-1931
    • Day, E.S.1    Cachero, T.G.2    Qian, F.3    Sun, Y.4    Wen, D.5    Pelletier, M.6    Hsu, Y.-M.7    Whitty, A.8
  • 37
    • 23044514711 scopus 로고    scopus 로고
    • Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha
    • DOI 10.1182/blood-2004-03-0889
    • Nishio M, Endo T, Tsukada N, et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood. 2005;106(3):1012- 1020. (Pubitemid 41076448)
    • (2005) Blood , vol.106 , Issue.3 , pp. 1012-1020
    • Nishio, M.1    Endo, T.2    Tsukada, N.3    Ohata, J.4    Kitada, S.5    Reed, J.C.6    Zvaifler, N.J.7    Kipps, T.J.8
  • 39
    • 8644243182 scopus 로고    scopus 로고
    • Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis
    • DOI 10.1182/blood-2003-11-3861
    • Bonci D, Hahne M, Felli N, Peschle C, De Maria R. Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis. Blood. 2004;104(10):3169-3172. (Pubitemid 39507131)
    • (2004) Blood , vol.104 , Issue.10 , pp. 3169-3172
    • Bonci, D.1    Hahne, M.2    Felli, N.3    Peschle, C.4    De Maria, R.5
  • 40
    • 77956916950 scopus 로고    scopus 로고
    • Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow
    • Winter O, Moser K, Mohr E, et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood. 2010;116(11):1867- 1875.
    • (2010) Blood , vol.116 , Issue.11 , pp. 1867-1875
    • Winter, O.1    Moser, K.2    Mohr, E.3
  • 41
    • 39149085356 scopus 로고    scopus 로고
    • high primary myeloma cells in SCID-hu mice and in coculture with osteoclasts
    • DOI 10.1038/sj.leu.2405048, PII 2405048
    • Yaccoby S, Pennisi A, Li X, et al. Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts. Leukemia. 2008;22(2):406-413. (Pubitemid 351250547)
    • (2008) Leukemia , vol.22 , Issue.2 , pp. 406-413
    • Yaccoby, S.1    Pennisi, A.2    Li, X.3    Dillon, S.R.4    Zhan, F.5    Barlogie, B.6    Shaughnessy Jr., J.D.7
  • 42
    • 70350734809 scopus 로고    scopus 로고
    • The microenvironment in mature B-cell malignancies: A target for new treatment strategies
    • Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 2009;114(16):3367-3375.
    • (2009) Blood , vol.114 , Issue.16 , pp. 3367-3375
    • Burger, J.A.1    Ghia, P.2    Rosenwald, A.3    Caligaris-Cappio, F.4
  • 43
    • 49349099119 scopus 로고    scopus 로고
    • Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy
    • Kim SJ, Lee SJ, Choi IY, et al. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy. Eur J Haematol. 2008;81(3):177-184.
    • (2008) Eur J Haematol , vol.81 , Issue.3 , pp. 177-184
    • Kim, S.J.1    Lee, S.J.2    Choi, I.Y.3
  • 44
    • 4043146475 scopus 로고    scopus 로고
    • B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation
    • Shulga-Morskaya S, Dobles M, Walsh ME, et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol. 2004;173(4):2331-2341. (Pubitemid 39063089)
    • (2004) Journal of Immunology , vol.173 , Issue.4 , pp. 2331-2341
    • Shulga-Morskaya, S.1    Dobles, M.2    Walsh, M.E.3    Ng, L.G.4    MacKay, F.5    Rao, S.P.6    Kalled, S.L.7    Scott, M.L.8
  • 46
    • 73949102012 scopus 로고    scopus 로고
    • Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus
    • Nestorov I, Papasouliotis O, Pena RC, Munafo A. Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus. J Pharm Sci. 2010;99(1):524-538.
    • (2010) J Pharm Sci , vol.99 , Issue.1 , pp. 524-538
    • Nestorov, I.1    Papasouliotis, O.2    Pena, R.C.3    Munafo, A.4
  • 47
    • 65149106325 scopus 로고    scopus 로고
    • An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
    • Pena-Rossi C, Nasonov E, Stanislav M, et al. An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus. Lupus. 2009;18(6):547-555.
    • (2009) Lupus , vol.18 , Issue.6 , pp. 547-555
    • Pena-Rossi, C.1    Nasonov, E.2    Stanislav, M.3
  • 48
    • 54349100000 scopus 로고    scopus 로고
    • Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: A phase I trial in patients with systemic lupus erythematosus
    • Furie R, Stohl W, Ginzler EM, et al. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther. 2008;10(5):R109.
    • (2008) Arthritis Res Ther , vol.10 , Issue.5
    • Furie, R.1    Stohl, W.2    Ginzler, E.M.3
  • 49
    • 63849239722 scopus 로고    scopus 로고
    • APRIL is overexpressed in cancer: Link with tumor progression
    • Moreaux J, Veyrune JL, De Vos J, Klein B. APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer. 2009;9:83.
    • (2009) BMC Cancer , vol.9 , pp. 83
    • Moreaux, J.1    Veyrune, J.L.2    De Vos, J.3    Klein, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.